Re: [方法] NAALADase Assays ?

看板Biotech作者 (we~we)時間16年前 (2010/02/28 01:57), 編輯推噓0(000)
留言0則, 0人參與, 最新討論串2/2 (看更多)
※ 引述《wei19850210 (we~we)》之銘言: : 如題~ : 我有點搞不清楚這段文章的敘述 : 對於這技術方法很不了解 不知道有沒有熟悉的好心人指導指導? : 文章內容如下: : NAALADase Assays. : NAAG hydrolysis was performed essentially as : described previously (9). In short, LNCaP cell extracts were prepared by : sonication in NAALADase buffer [50 mM Tris (pH 7.4) and 0.5% Triton : X-100]. Using this buffer, either cell lysate or purified xPSM was incubated in : the presence of the radiolabeled substrate N-acetyl-L-aspartyl-L-(3,4-3H)glutamate : (NEN Life Science Products, Boston, MA) at 37°C for 10–15 min. The : reaction was stopped by the addition of an equal volume of ice-cold 100-mM : sodium phosphate and 2 mM EDTA. Products were partitioned by AG 1-X8 : formate resin (Bio-Rad Laboratories) anion exchange chromatography, eluted : with 1 M sodium formate, and quantitated by scintillation counting. In general, : aptamer IC50 was determined in the presence of 8 nM NAAG with serially : diluted RNA. Aptamer Ki was determined using 5–30 nM aptamer in the : presence of serially diluted substrate. General NAALADase assays and : aptamer inhibition experiments showed no significant differences when done : in the presence of 1 mM of cobalt chloride. Trend lines were determined using : linear regression for Ki plots and logarithmic trend lines for enzyme kinetics, : applying R2 to determine fitness. : Points > 3 SD away from the mean were : considered outliers. Competitive inhibition Ki s were calculated by changes in : Km, where noncompetitive inhibition Kis were calculated by changes in Vmax. : Aptamer inhibition experiments were repeated at least once to confirm affinity : and mode of inhibition. Experiments were designed to allow 20% or less of the : total substrate to be cleaved. : By~ [CANCER RESEARCH 62, 4029–4033, July 15, 2002] 就是此酵素活性測定原理不是很了? 對於這方面 算是初學 可否大致說明 使我能較快理解 謝謝!! -- ※ 發信站: 批踢踢實業坊(ptt.cc) ◆ From: 59.112.226.45
文章代碼(AID): #1BYLpzzp (Biotech)
討論串 (同標題文章)
文章代碼(AID): #1BYLpzzp (Biotech)